The global Implantable Cardiac Rhythm Management Device market size was valued at US$ 14.60 billion in 2020 and is anticipated to grow at a CAGR of 6.1% during forecast period 2021 to 2028.
Increasing prevalence of cardiac disorders and growing geriatric population base are the major factors leading to the growth of this market. According to a report published by the Center for Diseases Control and Prevention (CDC) in 2017, Cardiovascular Diseases (CVDs) was the major cause of mortality in the U.S.
Stroke and ischemic heart disease are the major causes of more than 80 % of all CVD-related deaths. According to a report published by CDC in 2017, about 800,000 deaths occurred due to CVDs. In addition, Coronary Heart Disease (CHD) accounted for a majority of CVD deaths, followed by heart failure and stoke. Thus, the economic burden of CVDs is likely to be around USD 1,044 billion by 2030.
The CRM implantation is widely adopted in the treatment of sinus node dysfunction and conduction disorders. Increasing application of these devices for the treatment of arrhythmias and heart failure along with the ongoing clinical investigations are some of the major factors driving the market growth. Furthermore, initiatives, such as device registries by individual cardiologists and national societies, are expected to provide database for various manufacturers for product improvement, increasing market opportunities in the coming years.
In addition, increasing number of skilled physicians and healthcare practitioners and joint efforts of governments and major market participants to increase patient access to implantable cardiac pacemakers are expected to boost the market further. Advanced pacemaker technologies are also anticipated to drive market growth. For instance, according to CDC, in 2017, atrial fibrillation was the most common category of heart arrhythmia that has affected an estimated population of 2.7 to 6.1 million in the U.S.
Hospitals accounted for the leading market share in 2018 owing to deeper product penetration and huge volume of surgical procedures. Furthermore, the presence of favorable reimbursement facilities has led to its largest market share. Continuous efforts by the governments across the globe to reduce the burden of CVDs and the price of devices in hospitals, while increasing the awareness about reimbursement programs for CVD treatments are expected to provide newer opportunities in this segment.
Specialty cardiac centers are expected to grow at the highest CAGR from 2019 to 2026 due to various factors, such as increasing need for these centers, rising burden of CVDs, and demand for personalization of devices. Growing need for data preservation and remote monitoring are other factors leading to the increasing demand for specialty cardiac centers. Moreover, increasing need for outpatient services are further expected to propel the segment development.
North America held the major market share in the past due to factors, such as technological advancements, miniaturization, leadless or biocompatible materials, and government regulatory approvals. The market in Europe is expected to witness significant growth due to increased geriatric population, technological innovations, and growing prevalence of CVDs. The regional market is majorly dominated by a few companies, including Medtronic, St. Jude/Abbott, and Biotronik. Asia Pacific is projected to expand at the highest CAGR from 2019 to 2026.
Medtronic, St. Jude/Abbott, and Biotronik. Medtronic,
Specialty Cardiac Center
Middle East & Africa
The Implantable Cardiac Rhythm Management Device market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Implantable Cardiac Rhythm Management Device market for the base year 2020 and the forecast between 2021 and 2028. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Implantable Cardiac Rhythm Management Device market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Implantable Cardiac Rhythm Management Device market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Implantable Cardiac Rhythm Management Device market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Implantable Cardiac Rhythm Management Device capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Implantable Cardiac Rhythm Management Device by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Implantable Cardiac Rhythm Management Device market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2028. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Implantable Cardiac Rhythm Management Device market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Implantable Cardiac Rhythm Management Device market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Implantable Cardiac Rhythm Management Device industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
The Implantable Cardiac Rhythm Management Device market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Implantable Cardiac Rhythm Management Device market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Implantable Cardiac Rhythm Management Device market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Implantable Cardiac Rhythm Management Device market. These factors have benefited the growth of the global market for Implantable Cardiac Rhythm Management Device. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Implantable Cardiac Rhythm Management Device. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Implantable Cardiac Rhythm Management Device are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
Arrhythmia Monitoring Devices Market Size, Share, Growth, Trends, Consumption, Revenue, Company Analysis, Regional Insights and Forecast 2021-2030Read more...
Vaginitis Therapeutics Market Size, Share, Growth, Trends, Consumption, Revenue, Company Analysis, Regional Insights and Forecast 2021-2030Read more...
Botanicals Market Size, Share, Growth, Trends, Consumption, Revenue, Company Analysis, Regional Insights and Forecast 2021-2030Read more...
Stereotactic Surgery Devices Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030Read more...
Biopharmaceuticals Manufacturing Consumables Testing Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030Read more...